

[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
[ Thu, Nov 03rd 2016
] - WOPRAI
Andrew Peters of Deutsche Bank, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy on, Nov 3rd, 2016.
Andrew has made no other calls on BMRN in the last 4 months.
There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $127 on, Friday, August 5th, 2016
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $125 on, Friday, August 5th, 2016
Similar Stocks and Investing Articles
[ Fri, Oct 02nd 2015
] - WOPRAI
[ Wed, Aug 05th 2015
] - WOPRAI
[ Tue, Aug 04th 2015
] - WOPRAI
[ Thu, Jul 24th 2014
] - WOPRAI
[ Wed, Mar 20th 2013
] - WOPRAI
[ Tue, Nov 06th 2012
] - WOPRAI
[ Mon, Nov 05th 2012
] - WOPRAI
[ Thu, Sep 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI